MedTrace Logo

Cross-Cultural of the Validity, Reliability and Interpretability of Thai-version of Urticaria Control Test

NCT02285049 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 169

Last updated 2016-03-01

No results posted yet for this study

Summary

Chronic urticaria symptoms commonly fluctuate from day by day. Consequently the clinical presentation of a patient in each visit is not representative of the current disease status. Dermatologists are trying to integrate an evaluation process of each treatment visit regarding both clinical condition and life quality concern. The Urticaria Control Test is the key for a better treatment outcome in a routine management. To translate this questionnaire into Thai is essential in our subject of interest for offering local patients a higher well-being standard. The Thai-version test will encourage enhanced as well as impactful therapeutic options for Thai chronic urticaria patients.

Conditions

  • Chronic Urticaria

Interventions

OTHER

Urticaria Control Test

* The patients get the 1st UAS28 form and four-week appointment to follow up. * Collect completed UAS28 assessment, Patient's global assessment of disease severity (PatGA-LS) and Physician's global assessment of disease control (PhyGA-LS) * Then patients fill the 1st UCT and DLQI questionnaire by themselves. * The patients get the 2nd UAS28 form and four-week appointment to follow up. * At the 2nd visit, collect completed UAS28 assessment. Assessment the severity of chronic urticaria symptoms by Patient's global assessment of disease severity (PatGA-LS) and Physician's global assessment of disease control (PhyGA-LS). The patients fill the UCT and DLQI and questionnaire by themselves.

Sponsors & Collaborators

  • Charite University, Berlin, Germany

    collaborator OTHER

  • Mahidol University

    lead OTHER

Principal Investigators

  • Kanokwalai Kulthanan, MD · Mahidol University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2015-02-28
Completion
2016-01-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02285049 on ClinicalTrials.gov